Cart
sales@molnova.com
TDZD-8
CAS No. 327036-89-5
TDZD-8( TDZD 8 | TDZD8 | GSK-3β Inhibitor I | NP 01139 )
Catalog No. M14061 CAS No. 327036-89-5
A potent, selective, non-ATP competitive GSK-3β inhibitor with IC50 of 2 uM; displays no activity against PKA, CK-2, PKC, and CDK1 (IC50>100 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 44 | In Stock |
|
| 5MG | 40 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 50MG | 117 | In Stock |
|
| 100MG | 184 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTDZD-8
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, non-ATP competitive GSK-3β inhibitor with IC50 of 2 uM; displays no activity against PKA, CK-2, PKC, and CDK1 (IC50>100 uM).
-
DescriptionA potent, selective, non-ATP competitive GSK-3β inhibitor with IC50 of 2 uM; displays no activity against PKA, CK-2, PKC, and CDK1 (IC50>100 uM); reduces the colonic inflammation induced by TNBS in vivo, also prevents 6-OHDA-induced neuronal cell death.
-
In Vitro——
-
In Vivo——
-
SynonymsTDZD 8 | TDZD8 | GSK-3β Inhibitor I | NP 01139
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3β
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number327036-89-5
-
Formula Weight222.2636
-
Molecular FormulaC10H10N2O2S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(N1CC2=CC=CC=C2)N(C)SC1=O
-
Chemical Name1,2,4-Thiadiazolidine-3,5-dione, 2-methyl-4-(phenylmethyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Martinez A, et al. J Med Chem. 2002 Mar 14;45(6):1292-9.
2. Whittle BJ, et al. Br J Pharmacol. 2006 Mar;147(5):575-82.
3. Dugo L, et al. Crit Care Med. 2005 Sep;33(9):1903-12.
molnova catalog
related products
-
GSK-3β inhibitor 14
GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) is a weak GSK-3β inhibitor, IC50﹥ 100μM.
-
4-Chloro-2-bromoacet...
4-Chloro-2'-bromoacetophenone against glycogen synthase kinase-3 (GSK-3beta).
-
GS87
GS87 is a highly specific inhibitor of GSK3 (glycogen synthase kinase 3) that induces extensive differentiation of AML cells.GS87 potently inhibits growth of AML cells in mice with little effect on normal bone marrow cells. GS87 causes terminal differentiation of AML cells.
